Case Studies

30 Sep 2022 / Biotechnology / BTB program / Companies / Healthcare / Medical Technology / Pharmaceuticals / Researchers

BTB: Modernising Pain Management with 3D Drug Discovery Technology

Pain is a debilitating condition that affects approximately 20 per cent of the global adult population. Over the past few decades, escalating use of opioid therapeutics to manage pain has become a cause of concern in many countries. Aiming to establish alternative pain-relief therapies, Brisbane-based biotechnology company Vast Bioscience Pty Ltd is using a proprietary technology platform called VAST to develop three-dimensional small molecule sodium channel inhibitors.

11 Aug 2022 / Biotechnology / Clinical trials / Collaboration / GC Program / Healthcare / Manufacturing / Pharmaceuticals / Researchers / Services

CSIRO Opens Australia's New Biologics Manufacturing Facility for Clinical Trials

With the completion of CSIRO's National Vaccine and Therapeutics Lab in Melbourne, Australian SMEs and academics will for the first time be able to manufacture their biologics in Australia to prepare for human clinical trials.

25 Jul 2022 / BMTH program / Collaboration / Companies / Genomics Testing / Healthcare / Medical Technology / Researchers / Services

BMTH: Garvan Creates Australia's First Cancer Genomics Testing Service and Secures SydPath Deal

Cancer is a leading cause of death globally. So, a personalised genomics test for this complex disease has been on the medical wish list for a while. With funding from MTPConnect’s BioMedTech Horizons (BMTH) program, the Garvan Institute of Medical Research has developed a comprehensive cancer genomics platform for the Australian Healthcare sector with a single cost-effective test. The test is now available for use in routine clinical care through SydPath at St Vincent's Hospital in Sydney.

29 Jun 2022 / Clinical trials / Companies / Digital Health / Entrepreneurship / Healthcare / Medical Technology / Researchers

Case Study: Neurode Wave - changing the way ADHD is treated

Approximately one in every 20 Australians is affected by attention deficit hyperactivity disorder (ADHD), a developmental disorder that affects the brain's executive functioning causing impulsive behaviour, attention problems and, sometimes, hyperactivity. While medication is considered the first line treatment, 30 per cent of people with ADHD are drug resistant and, an even larger, 80 per cent still struggle daily with the symptoms of ADHD despite available treatment.

30 May 2022 / Biotechnology / Collaboration / Companies / Entrepreneurship / Pharmaceuticals / Services

Epichem’s Formula for Success and WA Connections

Epichem is a West Australian company formed in 2003 to provide services in synthetic and medicinal chemistry to the drug discovery and pharmaceutical industries. With a state-of-the-art laboratory in Technology Park, Western Australia, Epichem serves an international clientele ranging from small operations to large multinational pharmaceutical companies. The company has found it beneficial to connect with the MTPConnect WA Life Sciences Innovation Hub.

28 Apr 2022 / Biotechnology / Collaboration / Companies / REDI program / Researchers

APR.Intern Lights the Way for New Industry-University Collaboration on Disinfection Technology

With COVID-19 spreading by aerosols and contaminated surfaces in hospitals and healthcare settings, a medtech disinfection systems start-up, Mobile UV Innovations (MUVi), developed a new device that uses Ultraviolet photon light to rapidly disinfect hospitals. To fast-track testing, MUVi engaged a UNSW PhD intern via APR.Intern to ensure the new device's efficacy ... with great results.

30 Mar 2022 / BTB program / Clinical trials / Collaboration / Companies / Entrepreneurship / Healthcare / Medical Technology / Researchers / Start-Ups

BTB Case Study: Pioneering Australian technology is keeping hospitals COVID-safe

In the first year of the pandemic, a multidisciplinary team of world-leading experts led by the University of Melbourne created a groundbreaking patient isolation hood for Western Health - supported by MTPConnect's Biomedical Translation Bridge (BTB) program.

28 Feb 2022 / Biotechnology / BTB program / Companies / Entrepreneurship / Healthcare / Investors / Pharmaceuticals / Researchers

New drug treatment in development for patients living with liver disease

Bolstered by MTPConnect's BTB program, biotech company Cincera is developing a drug to treat severe and life-threatening liver diseases.

31 Jan 2022 / Collaboration / Companies / Entrepreneurship / Healthcare / Medical Technology / Researchers / Start-Ups

The birth of a WA start-up: VitalTrace biosensors seek to improve childbirth outcomes

Committed to empowering obstetricians and midwives to deliver the greatest outcomes for their patients, WA company VitalTrace is developing a highly accurate biosensor to improve the safety of mothers and babies during childbirth.

15 Dec 2021 / Biotechnology / BTB program / Collaboration / Companies / Pharmaceuticals / Researchers

BTB Case Study: Shining a light on collaboration to accelerate anti-cancer drug discovery

Melbourne-baesd MycRx is an early-stage drug development company advancing first-in-class small molecule inhibitors of the Myc oncoprotein to treat oncology indications such as lung cancer.

23 Nov 2021 / Biotechnology / Clinical trials / Healthcare / Pharmaceuticals / REDI program / Researchers

REDI: Empowering scientists with training in the growing clinical trials sector

Backed by MTPConnect's Researcher Exchange and Development within Industry initiative, the Victorian Comprehensive Cancer Centre Alliance's SKILLED internship program is generating a talent pipeline for the clinical trials sector.

27 Oct 2021 / Biotechnology / BMTH program / Companies / Entrepreneurship / Healthcare / Medical Technology / Researchers / Services

East meets West - The Chemistry of a Perfect Match for SpeeDx and SynGenis

A new partnership between Perth-based oligonucleotides manufacturer SynGenis and Sydney-based diagnostic company SpeeDx has led to an investment and collaboration between the two companies.

22 Sep 2021 / Companies / Entrepreneurship / Healthcare / Medical Technology / REDI program

REDI: Driving entrepreneurship education to solve global health challenges

Australian accelerator Health 10x is helping MUVi and other start-ups address some of the most testing global health challenges of our time, with support from MTPConnect's REDI initiative.

30 Aug 2021 / Companies / Digital Health / Healthcare / REDI program / Services

REDI: Mastering commercial success for digital health start ups

MTPConnect’s Researcher Exchange and Development within Industry initiative is supporting ANDHealth to deliver a Masterclass training program that propels digital health companies, such as uPaged, towards commercial success.